Invention Grant
- Patent Title: FLT3 receptor antagonists for the treatment or the prevention of pain disorders
-
Application No.: US16129955Application Date: 2018-09-13
-
Publication No.: US10781452B2Publication Date: 2020-09-22
- Inventor: Jean Valmier
- Applicant: Jean Valmier
- Applicant Address: FR Paris FR Montpellier
- Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE DE MONTPELLIER
- Current Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM),UNIVERSITE DE MONTPELLIER
- Current Assignee Address: FR Paris FR Montpellier
- Agency: W&C IP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@46ce0c01
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395 ; C07K16/28 ; C12N15/113 ; G01N33/50 ; A61K31/553 ; A61K31/404 ; C12N15/115 ; A61P29/00
Abstract:
The present invention relates to FLT3 receptor antagonists or inhibitors of FLT3 receptor gene expression for the treatment or the prevention of pain disorders.
Public/Granted literature
- US20190002888A1 FLT3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OR THE PREVENTION OF PAIN DISORDERS Public/Granted day:2019-01-03
Information query
